Literature DB >> 27613029

Combining Zebrafish and Mouse Models to Test the Function of Deubiquitinating Enzyme (Dubs) Genes in Development: Role of USP45 in the Retina.

Vasileios Toulis1, Alejandro Garanto1,2, Gemma Marfany3,4,5.   

Abstract

Ubiquitination is a dynamic and reversible posttranslational modification. Much effort has been devoted to characterize the function of ubiquitin pathway genes in the cell context, but much less is known on their functional role in the development and maintenance of organs and tissues in the organism. In fact, several ubiquitin ligases and deubiquitinating enzymes (DUBs) are implicated in human pathological disorders, from cancer to neurodegeneration. The aim of our work is to explore the relevance of DUBs in retinal function in health and disease, particularly since some genes related to the ubiquitin or SUMO pathways cause retinal dystrophies, a group of rare diseases that affect 1:3000 individuals worldwide. We propose zebrafish as an extremely useful and informative genetic model to characterize the function of any particular gene in the retina, and thus complement the expression data from mouse. A preliminary characterization of gene expression in mouse retinas (RT-PCR and in situ hybridization) was performed to select particularly interesting genes, and we later replicated the experiments in zebrafish. As a proof of concept, we selected ups45 to be knocked down by morpholino injection in zebrafish embryos. Morphant phenotypic analysis showed moderate to severe eye morphological defects, with a defective formation of the retinal structures, therefore supporting the relevance of DUBs in the formation and differentiation of the vertebrate retina, and suggesting that genes encoding ubiquitin pathway enzymes are good candidates for causing hereditary retinal dystrophies.

Entities:  

Keywords:  Deubiquitinating enzymes; Morpholino knockdown; Neurodegeneration; Retina; USP45; Zebrafish Animal Model

Mesh:

Substances:

Year:  2016        PMID: 27613029     DOI: 10.1007/978-1-4939-3756-1_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Delivery of Antisense Oligonucleotides to the Mouse Retina.

Authors:  Alejandro Garanto
Journal:  Methods Mol Biol       Date:  2022

2.  Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer.

Authors:  Kai Li; Qian Wang; Hua Bian; Zhiguo Chen; Haifa He; Xulin Zhao; Pengju Gong
Journal:  Front Mol Biosci       Date:  2022-06-28

3.  Expression of deubiquitinating enzyme genes in the developing mammal retina.

Authors:  Mariona Esquerdo-Barragán; Matthew J Brooks; Vasileios Toulis; Anand Swaroop; Gemma Marfany
Journal:  Mol Vis       Date:  2019-12-02       Impact factor: 2.367

4.  USP45 and Spindly are part of the same complex implicated in cell migration.

Authors:  Claudia Conte; Eric R Griffis; Ian Hickson; Ana B Perez-Oliva
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

5.  A New Cerkl Mouse Model Generated by CRISPR-Cas9 Shows Progressive Retinal Degeneration and Altered Morphological and Electrophysiological Phenotype.

Authors:  Elena B Domènech; Rosa Andrés; M José López-Iniesta; Serena Mirra; Rocío García-Arroyo; Santiago Milla; Florentina Sava; Jordi Andilla; Pablo Loza-Álvarez; Pedro de la Villa; Roser Gonzàlez-Duarte; Gemma Marfany
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

Review 6.  E3 ubiquitin ligase-mediated regulation of vertebrate ocular development; new insights into the function of SIAH enzymes.

Authors:  Warlen Pereira Piedade; Jakub K Famulski
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

7.  The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina.

Authors:  Vasileios Toulis; Sílvia García-Monclús; Carlos de la Peña-Ramírez; Rodrigo Arenas-Galnares; Josep F Abril; Sokol V Todi; Naheed Khan; Alejandro Garanto; Maria do Carmo Costa; Gemma Marfany
Journal:  Cell Rep       Date:  2020-11-10       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.